In the pediatric kidney transplant population, many patients are prescribed at least one teratogenic medication. Despite the potential dangers of unintended pregnancy with concomitant use of these medications, clinicians do not often assess or address these risks. The aim of this project was to 1) Conduct a chart review within a kidney transplant clinic to examine baseline practices on counseling around teratogen risks and referral to a specialist for contraception 2) Implement a standardized ?smart-phrase? template within the electronic medical record to prompt a discussion about teratogenic risk, remind the provider to consider a referral to a subspecialist for contraception counseling/provision, and help standardize documentation in all female pediatric patients 3) Conduct a post-intervention chart review to assess the outcomes of the quality improvement initiative.